SEC Form 4 · accession 0001140361-17-024752
Orgenesis Inc. · ORGS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vered Caplan
Officer — CEO · Director
Period of report
Jun 7, 2017
Accepted (ET)
Jun 12, 2017 · 8:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001460602
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy Common Stock)F1 | $0.60 | Jun 7, 2017 | A | 1,000,000 | A | Dec 7, 2017 | Jun 7, 2027 | Common Stock | 1,000,000 | 1,000,000 | D |
Explanation of responses
- F1The options were awarded under the Issuer's 2017 Equity Incentive Plan and are scheduled to vest in two equal installments of 500,000 option shares on each of December 7, 2017 and June 7, 2018 and are exercisable at a per share exercise price of $0.60.